Literature DB >> 23109135

Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.

Martin G Belinsky1, Lori Rink, Douglas B Flieder, Mona S Jahromi, Joshua D Schiffman, Andrew K Godwin, Margaret von Mehren.   

Abstract

Approximately 15% of gastrointestinal stromal tumors (GISTs) in adults and 85% in children lack mutations in KIT and PDGFRA and are known as wild-type GISTs. Wild-type GISTs from adults and children express high levels of insulin-like growth factor 1 receptor (IGF1R) and exhibit stable genomes compared to mutant GISTs. Pediatric wild-type GISTs, GISTs from the multitumor Carney-Stratakis syndrome, and the Carney triad share other clinicopathological properties (e.g., early-onset, multifocal GISTs with epitheliod cell morphology), suggesting a common etiology. Carney-Stratakis is an inherited association of GIST and paragangliomas caused by germline mutations in succinate dehydrogenase (SDH) genes. The connection between defective cellular respiration and GIST pathology has been strengthened by the utilization of SDHB immunohistochemistry to identify SDH deficiency in pediatric GISTs, syndromic GISTs, and some adult wild-type GISTs. SDHB and IGF1R expression was examined in 12 wild-type and 12 mutant GIST cases. Wild-type GISTs were screened for coding-region alterations in SDH genes and for chromosomal aberrations using genome-wide single-nucleotide polymorphism and MIP arrays. SDHB-deficiency, identified in 11/12 wild-type GIST cases, was tightly associated with overexpression of IGF1R protein and transcript. Biallelic inactivation of the SDHA gene was a surprisingly frequent event, identified in 5 of 11 SDHB-negative cases, generally due to germline point mutations accompanied by somatic SDHA allelic losses. As a novel finding, inactivation of the SDHC gene from a combination of a heterozygous coding-region mutation and hypermethylation of the wild-type allele was found in one SDHB-negative case.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109135      PMCID: PMC3564228          DOI: 10.1002/gcc.22023

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  56 in total

1.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

2.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

3.  SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Valentina Indio; Richard Moore; Nina Thiessen; Michael C Heinrich; Chiara Gnocchi; Donatella Santini; Fausto Catena; Serena Formica; Pier Luigi Martelli; Rita Casadio; Andrea Pession; Guido Biasco
Journal:  J Natl Cancer Inst       Date:  2011-04-19       Impact factor: 13.506

4.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

5.  Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.

Authors:  Markku Miettinen; Zeng-Feng Wang; Maarit Sarlomo-Rikala; Czeslaw Osuch; Piotr Rutkowski; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2011-11       Impact factor: 6.394

6.  Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.

Authors:  Lori Rink; Yuliya Skorobogatko; Andrew V Kossenkov; Martin G Belinsky; Thomas Pajak; Michael C Heinrich; Charles D Blanke; Margaret von Mehren; Michael F Ochs; Burton Eisenberg; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

7.  Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.

Authors:  Katherine A Janeway; Bernadette Liegl; Amy Harlow; Claudia Le; Antonio Perez-Atayde; Harry Kozakewich; Christopher L Corless; Michael C Heinrich; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.

Authors:  Katie T Huang; Alexander Dobrovic; Stephen B Fox
Journal:  BMC Res Notes       Date:  2009-09-25

9.  High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.

Authors:  Yuker Wang; Victoria E H Carlton; George Karlin-Neumann; Ronald Sapolsky; Li Zhang; Martin Moorhead; Zhigang C Wang; Andrea L Richardson; Robert Warren; Axel Walther; Melissa Bondy; Aysegul Sahin; Ralf Krahe; Musaffe Tuna; Patricia A Thompson; Paul T Spellman; Joe W Gray; Gordon B Mills; Malek Faham
Journal:  BMC Med Genomics       Date:  2009-02-19       Impact factor: 3.063

10.  A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.

Authors:  Patricia L M Dahia; Ken N Ross; Matthew E Wright; César Y Hayashida; Sandro Santagata; Marta Barontini; Andrew L Kung; Gabriela Sanso; James F Powers; Arthur S Tischler; Richard Hodin; Shannon Heitritter; Francis Moore; Robert Dluhy; Julie Ann Sosa; I Tolgay Ocal; Diana E Benn; Deborah J Marsh; Bruce G Robinson; Katherine Schneider; Judy Garber; Seth M Arum; Márta Korbonits; Ashley Grossman; Pascal Pigny; Sérgio P A Toledo; Vania Nosé; Cheng Li; Charles D Stiles
Journal:  PLoS Genet       Date:  2005-07-25       Impact factor: 5.917

View more
  36 in total

1.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

Review 2.  Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Authors:  Arathy S Kumar; Suresh K Rayala; Ganesh Venkatraman
Journal:  RNA Biol       Date:  2018-02-01       Impact factor: 4.652

Review 3.  GIST treatment options after tyrosine kinase inhibitors.

Authors:  Natthapol Songdej; Margaret von Mehren
Journal:  Curr Treat Options Oncol       Date:  2014-09

4.  Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

Authors:  Christopher L Corless; Karla V Ballman; Cristina R Antonescu; Violetta Kolesnikova; Robert G Maki; Peter W T Pisters; Martin E Blackstein; Charles D Blanke; George D Demetri; Michael C Heinrich; Margaret von Mehren; Shreyaskumar Patel; Martin D McCarter; Kouros Owzar; Ronald P DeMatteo
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

5.  SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors.

Authors:  G Herma Renkema; Saskia B Wortmann; Roel J Smeets; Hanka Venselaar; Marion Antoine; Gepke Visser; Tawfeg Ben-Omran; Lambert P van den Heuvel; Henri J L M Timmers; Jan A Smeitink; Richard J T Rodenburg
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

Review 6.  Molecular characterization and pathogenesis of gastrointestinal stromal tumor.

Authors:  Takeshi Niinuma; Hiromu Suzuki; Tamotsu Sugai
Journal:  Transl Gastroenterol Hepatol       Date:  2018-01-09

Review 7.  Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies.

Authors:  Joseph Vadakara; Margaret von Mehren
Journal:  Hematol Oncol Clin North Am       Date:  2013-10       Impact factor: 3.722

8.  Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Milena Urbini; Margherita Nannini; Paola Paterini; Valentina Indio; Maristella Saponara; Serena Formica; Claudio Ceccarelli; Rita Casadio; Giulio Rossi; Federica Bertolini; Donatella Santini; Maria G Pirini; Michelangelo Fiorentino; Umberto Basso; Guido Biasco
Journal:  Eur J Hum Genet       Date:  2013-04-24       Impact factor: 4.246

Review 9.  Connecting molecular pathways to hereditary cancer risk syndromes.

Authors:  Joseph R Testa; David Malkin; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

10.  Epigenetics in gastrointestinal stromal tumors: clinical implications and potential therapeutic perspectives.

Authors:  Athanasios D Sioulas; Diamantina Vasilatou; Vasiliki Pappa; George Dimitriadis; Konstantinos Triantafyllou
Journal:  Dig Dis Sci       Date:  2013-07-20       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.